Einstein Faculty

Einstein is home to more than 2,000 faculty members, who promote research and academic excellence at the College of Medicine.  In addition to conducting research in the institution’s 300 laboratories, these individuals serve as mentors and teachers to the medical school’s 724 M.D. students, 248 Ph.D. students, 117 M.D.-Ph.D. students and 368 postdoctoral research fellows. This page reflects resources and information useful to Einstein investigators, along with highlights pertaining to honors and events relevant to faculty.  Can't find a resource you need?  Please contact webrunners@einsteinmed.org to let us know.

Faculty Features

The Third Annual Einstein and Montefiore Presidential Lectures

On Monday, June 3 in Robbins Auditorium, Einstein and Montefiore hosted the third annual Presidential Lecture, which highlights outstanding research being done at the institutions. This year’s honorees were read more >

Dr. Jonathan Backer: Molecules by Day, Music by Night

Dr. Jonathan Backer is Einstein’s professor and chair of molecular pharmacology and a leading bench researcher on phosphoinositide 3-kinases, cellular proteins linked to various cancers. After hours, though, you read more >

Presidential Lecture Celebrates Innovative Research

On May 1, 2018, Betsy Herold, M.D. and William Jacobs Jr., Ph.D. presented their development of a novel vaccine to combat herpes simplex virus (HSV) at the Presidential Lecture read more >

 

Faculty Development Events

Thursday, October 28, 2021

"Getting Started with Promotions"

Time: 9:00 AM to 11:00 AM
Location: VIA Zoom

Monday, November 01, 2021

"Excel II: Formulas and Functions"

Time: 9:00 AM to 11:00 AM
Location: VIA Zoom

 
SEARCH 

Leadership Appointments

The Children’s Hospital at Montefiore (CHAM) and the department of pediatrics at Albert Einstein College of Medicine have recently added several key leaders to their ranks. Under the direction of Judy Aschner, M.D., physician-chief at CHAM and university chair, pediatrics at Einstein and Montefiore, the new recruitments and promotions include:

  • Patricia Hametz, M.D., M.P.H.
  • Suzette Oyeku, M.D., M.P.H.
  • Peter Belamarich, M.D.
  • Melissa Wasserstein, M.D

read more >

 

Academic Honors

Award to Tackle Lung Cancer—Cancer immunotherapy is a treatment strategy that “takes the brakes off” immune cells so they can attack cancer cells. These therapies have revolutionized cancer care. But not all patients respond, and scientists don’t fully understand why. Brendon Stiles, M.D., has received an Aspire Award from the Mark Foundation to investigate the potential benefits of blocking the enzyme ADP-ribosyltransferase 1(ART1), which is highly expressed on the cell surface of many non-small lung cancer tumors.

In previous research, Dr. Stiles found that ART1 blunts the body’s immune response against lung cancer. It does so by mono-ADP-ribosylating receptors on T cells and other immune cells, causing those cells to die. In work with mouse models of lung cancer, Dr. Stiles showed that inhibiting ART1 with a monoclonal antibody triggered an increase in immune cells that dramatically stopped the growth of lung cancer tumors. Now, Dr. Stiles will further explore the use of anti-ART1 monoclonal antibodies for treating lung cancer and assess whether the antibodies also help against other types of cancer. Dr. Stiles is assistant professor of cardiothoracic & vascular surgery at Einstein and associate director of surgical oncology at Albert Einstein Cancer Center.

view all